PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer

Figure 5

The association between PMEPA1 expression/methylation and clinicopathologic characteristics in CC, patients. (a)–(c) The association between PMEPA1 expressing and (a) age, (b) stage, and (c) grade in CC patients. (d)–(F) The association between PMEPA1 methylation and (d) age, (e) stage, and (f) grade in CC patients.

(a)

(b)

(c)

(d)

(e)

(f)